Charlie Kimball Partners With Novo Nordisk

Charlie Kimball is a successful young race car driver forging a career in the highly competitive world of open wheel racing. Kimball, who began racing go-karts at age 9, was accepted into Stanford University and chose to bypass admission to follow his dream to become a racecar driver.

In 2007, Kimball was diagnosed with type 1 diabetes and was forced to abandon his racing program mid-season. Today Kimball is the only licensed driver with diabetes in the history of the Indy Racing league.

After his surprising diagnosis, Kimball returned to the cockpit in 2008 and claimed a podium finish in his first race back in the car. Today, Kimball continues to compete in some of the most competitive racing categories in the world, proving that living with diabetes does not have to restrict him from traveling at speeds of more than 150 miles an hour and fulfilling his dream.

In fact, he has partnered with Novo Nordisk, a global healthcare company dedicated to diabetes care, to raise awareness of the importance of properly managing blood glucose levels and to demonstrate that diabetes can be successfully integrated into your life and your ambitions.

Kimball has a history of breaking the mold. Prior to his diagnosis, in 2005, Kimball shattered the European stereotype that “Americans are not fast” by becoming the first American in 11 years to win a British Formula 3 race. He went on to secure two track records and several Formula 3 victories in both Britain and Europe. Kimball has also raced in the Formula 3 Euro series and the World Series by Renault.

In 2009, Kimball returned to the United States as part of the Firestone Indy Lights series, finishing 10th overall. Kimball will pilot the No. 26 Novo Nordisk sponsored car for the legendary AFS Racing/Andretti Autosport and will run a full 13-race schedule on the 2010 Firestone Indy Lights series: